In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

Only two in five people taking GLP-1 medication were confident they would maintain their weight loss after stopping the ...

About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

In 2020, West Virginia started a pilot program providing subsidies for GLP-1 weight loss drugs for state employees. It showed ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

A registered dietitian shares the best diet and exercise tips to help optimize your GLP-1 response for faster weight loss.

If you’ve noticed ads for weight loss injections flood your social media feeds, you’re not alone. The soaring popularity of ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Allurion's new program uses artificial intelligence guidance to help patients adhere to a well-rounded diet and exercise ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...